BIOGEN INC. 8-K/A

What Happened

• Biogen Inc. filed an Item 9.01 Form 8-K on June 10, 2026, disclosing that financial statements and related exhibits tied to a merger were not included in its Original Report and will be provided by amendment.
• The company stated it will file the required financial statements relating to the merger by amendment no later than 71 calendar days after the date the Original Report was required to be filed. The filing also notes that, upon further analysis after the Original Report, Biogen determined additional financial statements are required.

Key Details

• Filing date: June 10, 2026 (Form 8-K, Item 9.01).
• Action: Biogen will amend the Original Report to include merger-related financial statements and exhibits.
• Deadline: Amendment and required financial statements to be filed within 71 calendar days of the Original Report’s required filing date.
• Trigger: Determination followed “further analysis” after the Original Report that additional financial statements were required.

Why It Matters

• For investors, this means the merger-related financial information is not yet available in the Original 8-K and will arrive later via an amendment. The forthcoming amendment should provide the financial details needed to assess the merger’s historical financial impact and any pro forma effects.
• Monitor Biogen’s amended filing and attached financial statements/exhibits when published, as they will contain material information relevant to valuation, accounting treatment and integration planning.